Role of ECM and inflammatory remodeling in alcohol-induced liver and lung damage-diversity supplement
Role of ECM and inflammatory remodeling in alcohol-induced liver and lung damage-diversity supplement
批准号:
9121282
负责人:
Gavin E Arteel
金额:
$2.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-02-01 至 2018-01-31
关键词:
AccountingAcuteAcute Lung InjuryAddressAlcohol abuseAlcohol consumptionAlcohol-Induced DisordersAlcoholic Liver DiseasesAlcoholsAnimalsCellsChronicClinicalDataDepositionDiseaseEndotoxemiaEpithelial CellsEthanolEventExtracellular MatrixFibrinFibrinolysisFunctional disorderGastrointestinal tract structureGenetic EngineeringGoalsHealthHepaticHepatotoxicityHypoxemiaIn SituIn VitroIncidenceIndividualInflammationInflammatoryInflammatory ResponseInjuryInterventionIntestinesInvestigationKupffer CellsLaboratoriesLeadLifeLinkLiverLungLung InflammationMediatingMediator of activation proteinModelingMorbidity - disease rateMusNicotinic ReceptorsOrganPeptide HydrolasesPlasminogen Activator Inhibitor 1PredispositionPreparationPulmonary EdemaRelative (related person)RiskRoleSeriesStructure of parenchyma of lungTestingTissuesTranslatingUp-RegulationWorkalcohol effectalcohol exposurealcohol responsebasein vivoliver inflammationliver injurylung injurymortalitynovelnovel therapeutic interventionnutritionproblem drinkerresponsetargeted treatment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overarching theme of this project is to study the role of nutrition and gut flora/intestinal dysfunction on alcohol-induced organ injury. We will focus on two organs that are the most common victims of chronic alcohol abuse: liver and lung. Specifically, we will examine how alcohol activates tissue remodeling in liver and lung through the induction of plasminogen activator inhibitor-1 (PAI-1) and the consequences of these events. Novel in vitro and in vivo approaches will be used to address mechanisms of action with the goal of identifying new targets for intervention. We propose that liver and lung share similar mechanisms of organ damage in response to alcohol. We specifically propose that PAI-1 induction and subsequent extracellular matrix (ECM) remodeling are key to the early inflammatory changes in both organs. Considering observations linking the effects of alcohol on tissue remodeling in both organs, we further propose that liver and lung not only share mechanisms of injury in response to alcohol, but that these mechanisms are linked and represent interdependent events. Based on these observations and other preliminary data, this proposal will test the hypothesis that alcohol, through the activation of nicotinic acetylcholine receptors (nAChRs), induces the expression of PAI-1 in both liver (e.g., Kupffer cells) and lung (Type II epithelial cells). This, in turn, triggers a series of downstream events that promote live and lung injury in response to endotoxemia derived from the GI tract. Moreover, we propose that liver-derived mediators further exacerbate lung injury through the induction of inflammation and tissue remodeling enhanced by inhibition of fibrinolysis. These hypotheses will be tested in the following Specific Aims: Aim 1: To explore the role of PAI-1 and nAChRs in the susceptibility of liver and lung to acute injury observed in the setting of chronic alcohol exposure. We hypothesize that alcohol stimulates the expression of PAI-1 in both liver and lung cells through effects on specific nAChRs. This in turn sensitizes both organs to acute injury (e.g. LPS). Aim 2: To test the hypothesis that liver-derived mediators are involved in pulmonary changes caused by chronic alcohol exposure and LPS- related organ damage. We propose that alcohol-induced damage to the liver sensitizes the host to acute lung injury in at-risk individuals. To test this, e plan to evaluate the effects of alcohol on lung injury in animals with reduced hepatotoxicity using
genetically engineered and chimeric mice. Aim 3: To determine the role of gut- derived products on alcohol-induced lung damage. Gut changes/injury caused by alcohol consumption could directly or indirectly damage liver and lung tissue. However, how gut:lung or gut:liver:lung interactions are influenced by alcohol remains unknown. We propose to test these concepts, and to explore the effect of novel therapeutic interventions that target the GI tract to protect th lung.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of matrix-bound microvesicles in alcohol-related liver disease
-
批准号:10582800
-
项目类别:
-
资助金额:$51.25万
-
财政年份:2023
-
负责人:Gavin E Arteel
-
依托单位:
Novel Biomarkers for Post-Liver Transplant NASH Fibrosis
-
批准号:10518842
-
项目类别:
-
资助金额:$71.25万
-
财政年份:2022
-
负责人:Gavin E Arteel
-
依托单位:
Novel Biomarkers for Post-Liver Transplant NASH Fibrosis
-
批准号:10667657
-
项目类别:
-
资助金额:$69.77万
-
财政年份:2022
-
负责人:Gavin E Arteel
-
依托单位:
Biomarkers of Alcoholic Hepatitis
-
批准号:10407997
-
项目类别:
-
资助金额:$59.08万
-
财政年份:2020
-
负责人:Gavin E Arteel
-
依托单位:
Biomarkers of Alcoholic Hepatitis
-
批准号:10631081
-
项目类别:
-
资助金额:$60.14万
-
财政年份:2020
-
负责人:Gavin E Arteel
-
依托单位:
Pilot and Feasibility
-
批准号:10117250
-
项目类别:
-
资助金额:$19.47万
-
财政年份:2019
-
负责人:Gavin E Arteel
-
依托单位:
Pilot and Feasibility
-
批准号:10372014
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2019
-
负责人:Gavin E Arteel
-
依托单位:
Pilot and Feasibility
-
批准号:10589770
-
项目类别:
-
资助金额:$19.47万
-
财政年份:2019
-
负责人:Gavin E Arteel
-
依托单位:
Liver-enriched Transcription Factors as Prognostic Markers and Therapeutic Targets in Alcoholic Hepatitis
-
批准号:10428560
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2018
-
负责人:Gavin E Arteel
-
依托单位:
Pilot Project Core
-
批准号:8978010
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2016
-
负责人:Gavin E Arteel
-
依托单位:
Role of ECM and inflammatory remodeling in alcohol-induced liver and lung damage
-
批准号:8435101
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2014
-
负责人:Gavin E Arteel
-
依托单位:
Role of ECM and inflammatory remodeling in alcohol-induced liver and lung damage
-
批准号:8794387
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2014
-
负责人:Gavin E Arteel
-
依托单位:
Control of drug and ethanol metabolism
-
批准号:7852205
-
项目类别:
-
资助金额:$13.08万
-
财政年份:2009
-
负责人:Gavin E Arteel
-
依托单位:
Priming of liver disease by arsenic exposure
-
批准号:7835781
-
项目类别:
-
资助金额:$22.11万
-
财政年份:2009
-
负责人:Gavin E Arteel
-
依托单位:
Priming of liver disease by arsenic exposure
-
批准号:7359863
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2009
-
负责人:Gavin E Arteel
-
依托单位:
UofL Environmental Health Sciences Training Program
-
批准号:9073542
-
项目类别:
-
资助金额:$46.34万
-
财政年份:2004
-
负责人:Gavin E Arteel
-
依托单位:
Digestive Diseases Training Program
-
批准号:10454309
-
项目类别:
-
资助金额:$24.52万
-
财政年份:2003
-
负责人:Gavin E Arteel
-
依托单位:
Digestive Diseases Training Program
-
批准号:10205027
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2003
-
负责人:Gavin E Arteel
-
依托单位:
Hypoxia and free radicals in alcoholic pancreatitis
-
批准号:6646393
-
项目类别:
-
资助金额:$10.95万
-
财政年份:2001
-
负责人:Gavin E Arteel
-
依托单位:
Hypoxia and free radicals in alcoholic pancreatitis
-
批准号:6785234
-
项目类别:
-
资助金额:$11.28万
-
财政年份:2001
-
负责人:Gavin E Arteel
-
依托单位:
海外基金